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Abstract. The aetiology of Kaposi's sarcoma remains 
obscure, however, epidemiological studies indicate that the 
disease possesses an infectious aetiology. Recent data 
revealed the presence of specific herpesvirus-like DNA 
sequences (KHSV) in all forms of Kaposi's sarcoma 
indicating that a novel virus may be the infectious agent 
which causes the disease. The aim of the present 
investigation was to assess the incidence of this herpesvirus-
like DNA sequence in 28 Mediterranean Kaposi's sarcomas. 
DNA was extracted from formalin-fixed paraffin-embedded 
tissues and analysed by a sensitive PCR based assay. The 
KSHV specific DNA sequences were found in 22 of 28 
(79%) cases suggesting a potential important role in the 
development of the disease. 
Introduction 
Kaposi's sarcoma (KS) is a multifocal hyperproliferative 
tumour of the skin and mucous membranes. Four main types 
of KS have been described, KS affecting elderly men, usually 
of Mediterranean origin (classical), endemic African KS, KS 
found in HIV positive patients (epidemic) and an iatrogenic 
form in association with immunocompromised patients (1). 
Apart from the involvement of endogenous factors such as 
cytokines (2) and oncogenes (3), epidemiological studies 
pointed in addition to the observation that immuno-
suppression predisposes to the development of KS, to the 
involvement of an infectious agent important for the 
development of the disease (4). A recent report of Chang et al 
(5) provided evidence for a novel herpes virus (KSHV) 
which is present in nearly 100% of the HIV-associated KS. 
Further studies (6-10) indicated that these KSHV sequences 
are also present in other forms of KS indicating an important 
Correspondence to: Professor D.A. Spandidos, Institute of 
Biological Research and Biotechnology, National Hellenic 
Research Foundation, 48 Vas. Constantinou Ave, Athens 116 35, 
Greece 
Key words: KSHV, PCR, Mediterranean Kaposi's sarcoma 
role for this virus in the development of this type of tumour. 
We investigated the presence of KSHV sequences by the 
polymerase chain reaction (PCR) in 28 Greek patients with 
KS suffering from the Mediterranean type of the disease. In 
Greece this type of KS is endemic in the Péloponnèse region 
with an incidence of 8 cases/106 people/year and thus it 
would be of particular interest to assess the presence of the 
novel virus in these specimens. 
Materials and methods 
DNA from paraffin-embedded tissues was extracted by 
proteinase K, phenol-chloroform extraction and ethanol 
precipitation as previously described (11). The primers and 
the conditions for the specific amplification of KSHV 
sequence have been described by Chang et al (5). 157 bp of 
the K-ras proto-oncogene were amplified using the primers 
5-ACTGAATATAAACTTGTGGTAGTTGGACCT-3 and 
5-TCAAAGAATGGTCCTGGACC-3. PCR programs were 
as follows: 95°C for 5 min and 35 cycles consisting of 95"C, 
56°C and 72°C for 20 sec, 40 sec and 1 min respectively. 
PCR products were electrophoresed in a 2% agarose gel, 
stained with ethidium bromide and scored for the presence of 
the specific 233 bp (KSHV) and 157 bp (K-ras) bands. 
Results and Discussion 
In the present study we investigated the incidence of KHSV 
DNA in 28 Mediterranean KS and in 2 HIV related KS in 
patients from Greece. The presence of KSHV DNA was 
revealed in both the HIV-positive specimens and in 22 
among 28 (79%) Mediterranean KS (Table I, Fig. 1). In order 
to evaluate the quality of the DNA for the PCR amplification, 
we amplified the K-ras proto-oncogene in all specimens. 
Although K-ras was amplifiable in all specimens by the first 
PCR, in KSHV 15 of the 22 (68%) positive specimens were 
scored as positive by the first PCR, while for the remaining 7 
specimens a second round of PCR amplification was 
required. Chang et al (5,6) reported that KSHV was present 
in approx. 1-2 copies per cell in KS. We may postulate that 
the inability of PCR to reveal the presence of the virus 
genome on the first round of amplification is due to the low 
copy number of the virus. Thus, the presence of the KSHV 
genome in the remaining 6 KSHV negative specimens should 
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Figure l. Detection of KSHV by PCR. Arrow indicates the 233 bp KSHV 
product. Lanes 1-3, positive specimens; lane 4, blank sample; M, pUC18/ 
HaelII. 
Table I. The presence of KSHV in association with clinico-
pathological parameters in Mediterranean Kaposi's sarcoma. 
Patient no. KSHV Sex Age 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+* 
+ 
+ 
+ 
+ 
+* 
+ 
+• 
+ 
+* 
+ 
+ 
+* 
+· 
+ 
M 
M 
F 
F 
M 
M 
M 
F 
F 
M 
F 
M 
M 
M 
F 
M 
62 
52 
76 
66 
60 
85 
52 
79 
52 
69 
80 
73 
M 
M 
F 
M 
72 
68 
80 
83 
66 
'indicates that a second round of amplification was required. 
be considered as a possibility but the low copy number of the 
virus in these specimens, in addition to the bad quality DNA 
(archive material from paraffin-embedded tissues) did not 
permit the amplification of these KSHV specific sequences. 
We also used two cases of HIV-positive KS as a positive 
control since KSHV was initially detected in this particular 
form of the disease. Negative specimens were reamplified by 
a second round of PCR in order to increase the sensitivity of 
the assay. In order to avoid false positive signals due to PCR 
c o n t a m i n a t i o n , samples wi thout D N A t e m p l a t e were 
included in the second round of PCR amplification. 
Although the presence of KSHV DNA is apparent in a 
significant proportion of KS specimens, several lines of 
evidence have cast doubt on the aetiological association of 
the virus with the disease. If indeed this novel virus causes 
KS, it should be expected to be present in a high copy 
number in the positive specimens. Furthermore, several KS 
cell lines did not harbour the KSHV specific sequences (12). 
In the present study we detected the novel herpesvirus-
like D N A sequences in a s igni f icant p r o p o r t i o n of 
Mediterranean KS indicating an association between KSHV 
and the development of the disease. However, the real 
significance of KSHV infection should be considered with 
caution since particular data (low copy number of the virus in 
the infected cells and the controversy between in vivo and 
in vitro results) suggest that KSHV may simply be an 
opportunistic infection. Further experiments are required in 
order to reveal the p a r t i c u l a r role of K S H V in the 
development of KS. 
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